These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11362188)

  • 1. 1995: business.
    AIDS Treat News; 1995 Jan; (No 214):7. PubMed ID: 11362188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-stage returns?
    Booth BL
    Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whatever happened to expanded access?
    Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the costs of pharmaceuticals.
    Valenti WM
    AIDS Read; 2004 Sep; 14(9):467-8, 471. PubMed ID: 15457597
    [No Abstract]   [Full Text] [Related]  

  • 5. Recall of AIDS drug hits world's poorest patients.
    AIDS Read; 2007 Sep; 17(9):439. PubMed ID: 17902224
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS epidemics--part two.
    Britton S
    Scand J Soc Med; 1988; 16(2):65-6. PubMed ID: 3291101
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS drug price hike prompts calls for intervention.
    Check E
    Nature; 2004 May; 429(6987):6. PubMed ID: 15129244
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in biopharmaceutical IPOS: 1996-2005.
    Williams DR; Young CC
    J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotech business Down Under.
    Beckley C
    Nature; 2004 Jun; 429(6991 Suppl):5-9. PubMed ID: 15175704
    [No Abstract]   [Full Text] [Related]  

  • 10. When your stock takes a nosedive.
    Jacobs T
    Nat Biotechnol; 2006 Feb; 24(2):144. PubMed ID: 16465152
    [No Abstract]   [Full Text] [Related]  

  • 11. Cheap AIDS drugs for developing countries.
    de Boer J
    Trends Cell Biol; 2001 Nov; 11(11):450. PubMed ID: 11684423
    [No Abstract]   [Full Text] [Related]  

  • 12. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 13. Petition fails to reverse massive price rise for AIDS drug.
    Check E
    Nature; 2004 Aug; 430(7001):715. PubMed ID: 15306778
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 15. [AIDS and social justice: pharmaceutical industry and economics].
    López Guzmán J
    Cuad Bioet; 2008; 19(67):563-74. PubMed ID: 19166259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The further evolution of biotech.
    Nagle T; Berg C; Nassr R; Pang K
    Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investors remain wary after first quarter downturn.
    Fletcher L
    Nat Biotechnol; 2002 May; 20(5):413-4. PubMed ID: 11981536
    [No Abstract]   [Full Text] [Related]  

  • 18. Brazil's WTO case has no bearing on AIDS.
    Holmer AF
    Nature; 2001 Jun; 411(6841):992. PubMed ID: 11429572
    [No Abstract]   [Full Text] [Related]  

  • 19. Investors likely to venture back as crisis subsides.
    Glick JL
    Nature; 2009 Aug; 460(7259):1079. PubMed ID: 19713912
    [No Abstract]   [Full Text] [Related]  

  • 20. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
    Reed SD; Califf RM; Schulman KA
    Health Aff (Millwood); 2006; 25(5):1309-17. PubMed ID: 16966727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.